Want to join the conversation?
$JNJ's unit Janssen Biotech said it has entered into a clinical study collaboration agreement with $BMY to evaluate combination of two immuno-oncology compounds in patients with non-small cell lung cancer (NSCLC). Both are currently in Phase 1 clinical development: JNJ-64041757 in lung cancer and JNJ-64041809 in prostate cancer.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.